Insmed
INSM
#542
Rank
NZ$75.31 B
Marketcap
NZ$353.12
Share price
-0.51%
Change (1 day)
173.45%
Change (1 year)

Revenue for Insmed (INSM)

Revenue in 2025 (TTM): NZ$0.77 Billion

According to Insmed's latest financial reports the company's current revenue (TTM ) is NZ$0.77 Billion. In 2024 the company made a revenue of NZ$0.64 Billion an increase over the revenue in the year 2023 that were of NZ$0.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insmed from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.77 B19.52%
2024 NZ$0.64 B33.63%
2023 NZ$0.48 B24.88%
2022 NZ$0.38 B40.06%
2021 NZ$0.27 B21.09%
2020 NZ$0.22 B12.45%
2019 NZ$0.20 B1281.99%
2018 NZ$14.66 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 NZ$13.99 M
2012 N/A-100%
2011 NZ$5.65 M-36.91%
2010 NZ$8.97 M-37.18%
2009 NZ$14.28 M-30.33%
2008 NZ$20.49 M110.1%
2007 NZ$9.75 M592.85%
2006 NZ$1.4 M634.68%
2005 NZ$0.19 M-0.18%
2004 NZ$0.19 M-16.79%
2003 NZ$0.23 M-93.82%
2002 NZ$3.73 M424.05%
2001 NZ$0.71 M-1228.17%
2000 -NZ$0.07 Million

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
NZ$4.17 B 439.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$97.57 B 12,510.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$50.34 B 6,406.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$2.30 B 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.37 B-52.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$20.29 B 2,522.53%๐Ÿ‡บ๐Ÿ‡ธ USA